Lance A. Parton

1.3k total citations
51 papers, 997 citations indexed

About

Lance A. Parton is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrine and Autonomic Systems. According to data from OpenAlex, Lance A. Parton has authored 51 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 12 papers in Endocrine and Autonomic Systems. Recurrent topics in Lance A. Parton's work include Neonatal Respiratory Health Research (31 papers), Congenital Diaphragmatic Hernia Studies (17 papers) and Respiratory Support and Mechanisms (15 papers). Lance A. Parton is often cited by papers focused on Neonatal Respiratory Health Research (31 papers), Congenital Diaphragmatic Hernia Studies (17 papers) and Respiratory Support and Mechanisms (15 papers). Lance A. Parton collaborates with scholars based in United States, Switzerland and Germany. Lance A. Parton's co-authors include Mustafa M. Siddiq, Upender K. Munshi, Dominique Belin, Anne Vassalli, M. O'Connell, J Huarte, Richard J. Rickles, J D Vassalli, Pascale Gubler and Sidney Strickland and has published in prestigious journals such as Genes & Development, PEDIATRICS and Journal of Applied Physiology.

In The Last Decade

Lance A. Parton

49 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lance A. Parton United States 15 575 342 261 190 127 51 997
Heidie Huyck United States 16 880 1.5× 609 1.8× 375 1.4× 156 0.8× 97 0.8× 26 1.3k
Orion P. Twentyman United Kingdom 14 1.3k 2.3× 154 0.5× 136 0.5× 46 0.2× 45 0.4× 20 2.1k
Gertrud Vieten Germany 15 293 0.5× 218 0.6× 67 0.3× 71 0.4× 25 0.2× 43 591
Hara Levy United States 20 682 1.2× 140 0.4× 243 0.9× 12 0.1× 69 0.5× 39 1.1k
Judie A. Howrylak United States 13 344 0.6× 75 0.2× 423 1.6× 31 0.2× 24 0.2× 22 996
Marie Geerlings Netherlands 16 494 0.9× 83 0.2× 208 0.8× 27 0.1× 27 0.2× 19 1.2k
Karen E. Edeen United States 12 324 0.6× 131 0.4× 234 0.9× 32 0.2× 16 0.1× 14 812
Stephen M. Mongovin United States 9 310 0.5× 48 0.1× 216 0.8× 166 0.9× 10 0.1× 14 748
Enrique Rodrı́guez Spain 23 177 0.3× 364 1.1× 181 0.7× 48 0.3× 11 0.1× 63 1.7k
William G. Figueroa United States 13 207 0.4× 143 0.4× 101 0.4× 33 0.2× 48 0.4× 20 1.2k

Countries citing papers authored by Lance A. Parton

Since Specialization
Citations

This map shows the geographic impact of Lance A. Parton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance A. Parton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance A. Parton more than expected).

Fields of papers citing papers by Lance A. Parton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance A. Parton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance A. Parton. The network helps show where Lance A. Parton may publish in the future.

Co-authorship network of co-authors of Lance A. Parton

This figure shows the co-authorship network connecting the top 25 collaborators of Lance A. Parton. A scholar is included among the top collaborators of Lance A. Parton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance A. Parton. Lance A. Parton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isath, Ameesh, et al.. (2023). Nationwide Analysis of the Outcomes and Mortality of Hospitalized Infants with Concomitant Diagnosis of COVID-19. American Journal of Perinatology. 41(S 01). e2727–e2734. 1 indexed citations
2.
Parton, Lance A., et al.. (2021). Hedgehog signaling pathway gene variant influences bronchopulmonary dysplasia in extremely low birth weight infants. World Journal of Pediatrics. 17(3). 298–304. 5 indexed citations
3.
Parton, Lance A., et al.. (2012). PP128. Placental Caspase-3 gene polymorphisms is associated with preeclampsia. Pregnancy Hypertension. 2(3). 308–308. 5 indexed citations
4.
Parton, Lance A., et al.. (2012). PP126. Are placental fas and fas ligand gene polymorphisms associated with preeclampsia?. Pregnancy Hypertension. 2(3). 307–307. 4 indexed citations
5.
Parton, Lance A., et al.. (2012). Are placental Fas and Fas ligand gene polymorphisms associated with preeclampsia?. Pregnancy Hypertension. 3(1). 34–38. 3 indexed citations
7.
Haleem, Abdul, et al.. (2010). Bedside Lung Mechanics Predict Survival in Hypoplastic Lung Disease. American Journal of Perinatology. 28(4). 305–314. 4 indexed citations
8.
Cristea, Ioana A., et al.. (2010). Does surfactant type cause a differential proinflammatory response in preterm infants with respiratory distress syndrome?. Advances in Therapy. 27(7). 476–482. 6 indexed citations
9.
Parton, Lance A., et al.. (2008). Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study. Journal of Perinatology. 29(4). 297–304. 18 indexed citations
10.
Ballard, Philip L., Jeffrey D. Merrill, William E. Truog, et al.. (2007). Surfactant Function and Composition in Premature Infants Treated With Inhaled Nitric Oxide. PEDIATRICS. 120(2). 346–353. 24 indexed citations
11.
Parton, Lance A., et al.. (2005). Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. American Journal of Obstetrics and Gynecology. 193(3). 1132–1136. 21 indexed citations
12.
Siddiq, Mustafa M., et al.. (2004). Interleukin-1 Balance in the Lungs of Preterm Infants Who Develop Bronchopulmonary Dysplasia. Neonatology. 87(2). 82–90. 36 indexed citations
13.
Davis, Jonathan M., Susan E. Richter, Warren Rosenfeld, et al.. (2000). Long-Term Follow-up of Premature Infants Treated With Prophylactic, Intratracheal Recombinant Human CuZn Superoxide Dismutase. Journal of Perinatology. 20(4). 213–216. 28 indexed citations
14.
Roche, Patricia, et al.. (1999). Isolated bilateral submandibular abscesses in a preterm infant: a case report. International Journal of Pediatric Otorhinolaryngology. 51(1). 47–50. 9 indexed citations
15.
Parton, Lance A., et al.. (1999). Elevation of the Proinflammatory Cytokine Interleukin 1 (IL-1) in Tracheal Aspirates (TA) from Preterm Infants Who Progress to Bronchopulmonary Dysplasia (BPD). Pediatric Research. 45(4, Part 2 of 2). 203A–203A. 1 indexed citations
16.
Singhal, Kamal Kumar & Lance A. Parton. (1996). Plasminogen Activator Activity in Preterm Infants with Respiratory Distress Syndrome: Relationship to the Development of Bronchopulmonary Dysplasia. Pediatric Research. 39(2). 229–235. 20 indexed citations
17.
Parton, Lance A., David Warburton, & Walter E. Laug. (1992). Plasminogen Activator Inhibitor Type 1 Production by Rat Type II Pneumocytes in Culture. American Journal of Respiratory Cell and Molecular Biology. 6(2). 133–139. 12 indexed citations
18.
Warburton, David, et al.. (1988). Chronic Glucose Infusion Inhibits Development of β-Receptor Binding in Fetal Lamb Lung. Pediatric Research. 24(2). 171–174. 3 indexed citations
19.
Warburton, David, et al.. (1988). Effects of β-2 Agonist on Hepatic Glycogen Metabolism in the Fetal Lamb. Pediatric Research. 24(3). 330–332. 5 indexed citations
20.
Warburton, David, et al.. (1987). Effects of beta-2 agonist on tracheal fluid flow, surfactant and pulmonary mechanics in the fetal lamb.. Journal of Pharmacology and Experimental Therapeutics. 242(2). 394–398. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026